Advancing clinical-stage therapeutics for Parkinson's and neurodegeneration.

Each of us has been affected by Parkinson's, dementia or other disease of the brain. We are the children, partners and friends of people living with neurodegenerative diseases. Sometimes, we are patients ourselves. Current drugs are marginally effective and can often make symptoms worse.

New drugs keep failing in clinical trials.

At Blackfynn, we do things differently. By applying a systematic approach that combines data, technology and deep domain expertise, we are developing a pipeline of targeted, clinical-stage therapeutics to improve the lives of those living with Parkinson's and other neurodegenerative diseases.

Join Blackfynn

Brain diseases are the biggest cause of disability and the second leading cause of death worldwide. The global burden of Parkinson's has more than doubled in the past generation, to 10 million people. The same flawed approach continues to drive failures of promising therapeutics in late-stage development, leaving millions of people with limited therapeutic options. Blackfynn's mission is to change this paradigm.

We are looking for passionate, talented, collaborative problem-solvers who want to use their skills to make a positive impact for patients. Join Blackfynn and be part of mission-driven team with a goal to improve the lives of people with neurodegenerative diseases.

Contact Us

Looks like there's a problem with your message. Check the contact form for errors and try sending the message again.

Your message has been sent.

General
press@blackfynn.com

Phone Number
267.455.0088

Location
Blackfynn, Inc.
1218 Chestnut Street
8th Floor
Philadelphia, PA 19107

Twitter LinkedIn icon GitHub Close menu Menu Google blackfynn_logo_mark_RGB_FULL Monogram Dribbble